These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35306980)

  • 1. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients.
    Hasparyk UG; Vigil FMB; Bartolomei VS; Nunes VM; Simões E Silva AC
    Curr Med Chem; 2022 Aug; 29(31):5230-5253. PubMed ID: 35306980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKD-MBD post kidney transplantation.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2021 Jan; 36(1):41-50. PubMed ID: 31858226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
    Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
    Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in bone density and microarchitecture in adolescents undergoing a first kidney transplantation: a prospective study.
    De Mul A; Leclerc AS; Ginhoux T; Levi C; Confavreux C; Aurelle M; Portefaix A; Bacchetta J
    Eur J Pediatr; 2024 Dec; 183(12):5303-5312. PubMed ID: 39384649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic bone disease after renal transplantation.
    Haffner D; Schüler U
    Curr Opin Pediatr; 2014 Apr; 26(2):198-206. PubMed ID: 24535492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
    Hu L; Napoletano A; Provenzano M; Garofalo C; Bini C; Comai G; La Manna G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its Management.
    Pazianas M; Miller PD
    J Bone Miner Res; 2020 Dec; 35(12):2313-2317. PubMed ID: 32780482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Mineral Disease After Kidney Transplantation.
    Torregrosa JV; Ferreira AC; Cucchiari D; Ferreira A
    Calcif Tissue Int; 2021 Apr; 108(4):551-560. PubMed ID: 33765230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between kidney and bone: insights from CKD-MBD.
    Suzuki K; Soeda K; Komaba H
    J Bone Miner Metab; 2024 Jul; 42(4):463-469. PubMed ID: 39060498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.
    Kalantar-Zadeh K; Shah A; Duong U; Hechter RC; Dukkipati R; Kovesdy CP
    Kidney Int Suppl; 2010 Aug; (117):S10-21. PubMed ID: 20671739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy.
    Cianciolo G; Galassi A; Capelli I; Angelini ML; La Manna G; Cozzolino M
    Am J Nephrol; 2016; 43(6):397-407. PubMed ID: 27229347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Disease in Chronic Kidney Disease and Kidney Transplant.
    Bellorin-Font E; Rojas E; Martin KJ
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
    Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteo-renal regulation of systemic phosphate metabolism.
    Razzaque MS
    IUBMB Life; 2011 Apr; 63(4):240-7. PubMed ID: 21438115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic kidney disease - Mineral bone disorders: Physiopathology and guidelines].
    Lavainne F; Guillot P; Figueres L
    Rev Med Interne; 2022 Apr; 43(4):225-232. PubMed ID: 35227526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.